Skip to main content
. 2019 Nov 5;8(11):e01088. doi: 10.1002/cti2.1088

Table 4.

Characteristics of patients treated with CMV‐specific T‐cell therapy

Patient cohort (n = 12) Range Median
Min Max
Age at consent (year) 38.3 75.1 54.6
Age at diagnosis (year) 32.6 74.0 52.2
OS following first infusion (months) 1.1 109.0 10.7
PFS following first infusion (months) 0.7 109.0 5.8

OS, overall survival; PFS, progression‐free survival.